<DOC>
	<DOCNO>NCT01900886</DOCNO>
	<brief_summary>Primary objective : Evaluate prevalence personality disorder patient start treatment hepatitis C prison determine influence evolution disease .</brief_summary>
	<brief_title>Epidemiological Study Evaluate Personality Disorders Prison Populations Treatment Hepatitis C</brief_title>
	<detailed_description>Secondary objective : - Describe management patient personality disorder treatment hepatitis C prison . - Describe characteristic patient discontinue treatment reason stratify presence personality disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Patients 18 year age . Patients expect prison stay beyond duration followup period study . Patients chronic HCV infection detectable viral load initiate treatment standard therapy . Patients write informed consent participate study . Patients previously treat Interferon ( IFN ) Ribavirin ( RBV ) . Patients read understand write questionnaire discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>prison , disorder , hepatitis c</keyword>
</DOC>